SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000936392-06-000764
Filing Date
2006-08-04
Accepted
2006-08-04 16:34:35
Documents
4
Period of Report
2006-07-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K DATED JULY 31, 2006 a22707e8vk.htm 8-K 17810
2 EXHIBIT 10.1 a22707exv10w1.htm EX-10.1 100243
3 EXHIBIT 10.2 a22707exv10w2.htm EX-10.2 10665
4 EXHIBIT 99.1 a22707exv99w1.htm EX-99.1 6306
  Complete submission text file 0000936392-06-000764.txt   136737
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 8585507500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20720 | Film No.: 061006235
SIC: 2834 Pharmaceutical Preparations